80
Participants
Start Date
March 18, 2024
Primary Completion Date
March 31, 2027
Study Completion Date
September 30, 2028
Recombinant Zoster Vaccine
After giving consent, participants will be given first dose of vaccine. Participants will be brought back 60-90 days post-vaccine for follow up testing and second dose of vaccine
Ann & Robert H. Lurie Children's Hospital, Chicago
Children's Hospital Colorado
OTHER
Children's Hospital Medical Center, Cincinnati
OTHER
Ann & Robert H Lurie Children's Hospital of Chicago
OTHER